New Zealand markets closed

Lifecore Biomedical, Inc. (LFCR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.87+0.10 (+1.73%)
At close: 04:00PM EDT
5.87 0.00 (0.00%)
After hours: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 179.31M
Enterprise value 272.84M
Trailing P/E N/A
Forward P/E 10.12
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.70
Price/book (mrq)1.57
Enterprise value/revenue 2.64
Enterprise value/EBITDA -13.49

Trading information

Stock price history

Beta (5Y monthly) 0.98
52-week change 39.51%
S&P500 52-week change 326.49%
52-week high 311.46
52-week low 34.50
50-day moving average 36.32
200-day moving average 37.24

Share statistics

Avg vol (3-month) 3200.64k
Avg vol (10-day) 3141.17k
Shares outstanding 530.55M
Implied shares outstanding 630.55M
Float 817.28M
% held by insiders 14.53%
% held by institutions 175.77%
Shares short (30 Apr 2024) 41.98M
Short ratio (30 Apr 2024) 410.91
Short % of float (30 Apr 2024) 49.39%
Short % of shares outstanding (30 Apr 2024) 46.49%
Shares short (prior month 28 Mar 2024) 41.79M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 28 May 2023
Most-recent quarter (mrq)28 May 2023

Profitability

Profit margin -96.41%
Operating margin (ttm)-7.68%

Management effectiveness

Return on assets (ttm)-4.67%
Return on equity (ttm)-104.52%

Income statement

Revenue (ttm)103.27M
Revenue per share (ttm)3.45
Quarterly revenue growth (yoy)20.80%
Gross profit (ttm)N/A
EBITDA -9.92M
Net income avi to common (ttm)-64.24M
Diluted EPS (ttm)-2.14
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)19.09M
Total cash per share (mrq)0.62
Total debt (mrq)177.52M
Total debt/equity (mrq)505.94%
Current ratio (mrq)2.39
Book value per share (mrq)-0.14

Cash flow statement

Operating cash flow (ttm)-17.44M
Levered free cash flow (ttm)15.96M